Anson Funds Management LP

Insider Reports History

Location
Dallas, TX
Signature
/s/ Tony Moore, manager of Anson Management GP LLC, general partner of Anson Funds Management LP
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anson Funds Management LP:

Company Role Class Num Shares Value Price $ Report Date Ownership
MEI Pharma, Inc. 10%+ Owner Common Stock 1,093,188 $7,652,316 $7.00 20 Oct 2023 Indirect
Trilogy International Partners Inc. 10%+ Owner Common Shares, no par value 8,980,250 20 Dec 2023 Indirect
MEI Pharma, Inc. 10%+ Owner Put Option (obligation to buy) 0 20 Oct 2023 Indirect

Insider Reports Filed by Anson Funds Management LP

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000095017024019892-anson-funds-management-lp-2023-11-14 Trilogy International Partners Inc. 14 Nov 2023 4 -$29,862 4 10%+ Owner 26 Feb 2024, 13:29
MEIP MEI Pharma, Inc. 20 Oct 2023 5 +$1,253,000 4 10%+ Owner 24 Oct 2023, 19:32
MEIP MEI Pharma, Inc. 11 Oct 2023 4 +$350,000 4 10%+ Owner 13 Oct 2023, 17:02
MEIP MEI Pharma, Inc. 22 Sep 2023 2 +$328,011 4 10%+ Owner 25 Sep 2023, 20:43
MEIP MEI Pharma, Inc. 20 Sep 2023 2 +$938,226 4 10%+ Owner 22 Sep 2023, 22:21
MEIP MEI Pharma, Inc. 19 May 2023 0 $0 3 10%+ Owner 30 May 2023, 21:44
/report/000089924323001750-anson-funds-management-lp-2023-01-01 Trilogy International Partners Inc. 01 Jan 2023 0 $0 3 10%+ Owner 13 Jan 2023, 15:39